1-9 of 9
Jelle Adelmeijer
Close
Sort by
Journal Articles

Anticoagulant activity of edoxaban in patients with cirrhosis

Clinical Trials & Observations
Sarah Bos, Tim Schreuder, Hans Blokzijl, Jelle Adelmeijer, Ton Lisman, Pieter W. Kamphuisen
Journal: Blood
Blood (2020) 136 (13): 1561–1564.
https://doi.org/10.1182/blood.2020005319
Published: 2020
Journal Articles

Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans

Dafna Groeneveld, David Pereyra, Zwanida Veldhuis, Jelle Adelmeijer, Petra Ottens, Anna K. Kopec, Patrick Starlinger, Ton Lisman, James P. Luyendyk
Journal: Blood
Blood (2019) 133 (11): 1245–1256.
https://doi.org/10.1182/blood-2018-08-869057
Published: 2019
Includes: Supplemental data
Journal Articles

Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation

Marc Kirschbaum, Golnar Karimian, Jelle Adelmeijer, Ben N. G. Giepmans, Robert J. Porte, Ton Lisman
Journal: Blood
Blood (2015) 126 (6): 798–806.
https://doi.org/10.1182/blood-2014-09-600312
Published: 2015
Includes: Supplemental data
Journal Articles

Infusion of DDAVP Does Not Improve Primary Hemostasis in Patients with Cirrhosis

Freeha Arshad, Sara C.M. Stoof, Frank W.G. Leebeek, Karin Ruitenbeek, Jelle Adelmeijer, Hans Blokzijl, Arie P. van den Berg, Robert J. Porte, Marieke J.H.A. Kruip, Ton Lisman
Journal: Blood
Blood (2014) 124 (21): 5044.
https://doi.org/10.1182/blood.V124.21.5044.5044
Published: 2014
Journal Articles

The glycoprotein Ib-IX-V complex contributes to tissue factor–independent thrombin generation by recombinant factor VIIa on the activated platelet surface

Cees Weeterings, Philip G. de Groot, Jelle Adelmeijer, Ton Lisman
Journal: Blood
Blood (2008) 112 (8): 3227–3233.
https://doi.org/10.1182/blood-2008-02-139113
Published: 2008
Includes: Supplemental data
Journal Articles

Recombinant Factor VIIa Enhances Platelet Adhesion and Aggregation under Flow Conditions at Normal and Reduced Platelet Count.

Ton Lisman, PhD, Jelle Adelmeijer, Bsci, Sandra Cauwenberghs, MSci, Elisabeth C.M. van Pampus, MD, Johan W.M. Heemskerk, PhD, Philip G. de Groot, PhD
Journal: Blood
Blood (2004) 104 (11): 2618.
https://doi.org/10.1182/blood.V104.11.2618.2618
Published: 2004
Journal Articles

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Ton Lisman, PhD, Philip G. de Groot, PhD, Jelle Adelmeijer, BSci, Joost C.M. Meijers, PhD, Frits R. Rosendaal, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2597.
https://doi.org/10.1182/blood.V104.11.2597.2597
Published: 2004
Journal Articles

Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation

Ton Lisman, Jelle Adelmeijer, Harry F. G. Heijnen, Philip G. de Groot
Journal: Blood
Blood (2004) 103 (5): 1720–1727.
https://doi.org/10.1182/blood-2003-07-2287
Published: 2004
Journal Articles

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired α IIb β 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation

Ton Lisman, Sultana Moschatsis, Jelle Adelmeijer, H. Karel Nieuwenhuis, Philip G. De Groot
Journal: Blood
Blood (2003) 101 (5): 1864–1870.
https://doi.org/10.1182/blood-2002-09-2761
Published: 2003